• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Defining airflow obstruction as FEV1:FVC of less than 0.70 optimal compared to other fixed thresholds for COPD

byJason Nam, MDandDaniel Fisher
June 27, 2019
in Chronic Disease, Public Health, Pulmonology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, an FEV1:FVC threshold of 0.71 was the best fit for discriminating COPD-related events, though it was not statistically different than using 0.70.

2. The FEV1:FVC 0.70 threshold provided optimal discrimination in a subgroup analysis of ever smokers and in adjusted models.

Evidence Rating Level: 2 (Good)

Study Rundown: Current respiratory society guidelines recommend diagnosing airflow obstruction when the ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV1:FVC) is less than a fixed threshold of 0.70. However, there is little empirical data supporting this cut-off versus others, such as the lower-limit of normal (LLN) based on demographic and clinical factors. In this retrospective cohort, the accuracy of various FEV1:FVC fixed thresholds for predicting COPD-related hospitalization and mortality was investigated. An FEV1:FVC threshold of 0.71 was the best fit for discriminating COPD-related events, though it was not statistically different than using 0.70. However, the 0.70 threshold did have better discriminative accuracy than the LLN. The FEV1:FVC 0.70 threshold provided optimal discrimination in a subgroup analysis of ever smokers and in adjusted models.

While this study suggests that the 0.70 threshold is appropriate for COPD, some limitations should be noted. For instance, GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines recommend using post-bronchodilator values for confirming airflow obstruction, while this study used pre-bronchodilator spirometry. Further, there were no adjustments made for medication use. Finally, the composite of COPD-related hospitalization and mortality was selected as the primary outcome and probably excluded a large number of participants with mild-to-moderate disease who suffer exacerbations.

Click to read the study in JAMA

RELATED REPORTS

Verona’s Ohtuvayre shows promise in the treatment and management of Chronic Obstructive Pulmonary Disease

#VisualAbstract: Tezepelumab Does Not Reduce Exacerbations in Adults with Chronic Obstructive Pulmonary Disease

#VisualAbstract: High-Intensity Noninvasive Positive Pressure Ventilation Reduces Need for Endotracheal Intubation in COPD

Click to read an accompanying editorial in JAMA

Relevant Reading: Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV1/FVC.

In-Depth [retrospective cohort]: The National Heart, Lung, and Blood Institute Pooled Cohorts Study included 24,207 participants from 4 US general population–based cohorts. The primary outcome was a composite of COPD-related mortality and COPD-related hospitalization. Analyses were conducted on FEV1:FVC thresholds 0.65 to 0.75 and the LLN> In the primary analysis, the 0.71 FEV1:FVC threshold demonstrated the highest C-statistic (0.696; CI95 0.688 to 0.703). The 0.71 discrimination threshold was not significantly different from the 0.70 threshold (difference 0.001; CI95 −0.002 to 0.004). It was significantly more accurate than the LLN threshold (difference 0.034; CI95, 0.028 to 0.041). The sensitivity for the LLN was 52%, and the specificity for the LLN was 89%, which approximated the results for a fixed 0.66 threshold. The 0.70 threshold had a sensitivity of 66%, and the specificity was 79%. The optimal fixed threshold was 0.70 in ever smokers and in men, 0.71 for COPD-related hospitalizations, and 0.69 for the events for which COPD was the primary or underlying cause.

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chronic obstructive pulmonary disease (COPD)FEVGOLD criteria
Previous Post

Quick Take: Suicide in older adults living in or transitioning to residential long-term care, 2003 to 2015

Next Post

The MR-INFORM trial: fewer patients undergo revascularization when coronary perfusion is assessed with MRI compared to invasive angiography

RelatedReports

2 Minute Medicine Rewind May 20, 2019
Pharma

Verona’s Ohtuvayre shows promise in the treatment and management of Chronic Obstructive Pulmonary Disease

January 20, 2025
#VisualAbstract: Tezepelumab Does Not Reduce Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
StudyGraphics

#VisualAbstract: Tezepelumab Does Not Reduce Exacerbations in Adults with Chronic Obstructive Pulmonary Disease

December 23, 2024
#VisualAbstract: High-Intensity Noninvasive Positive Pressure Ventilation Reduces Need for Endotracheal Intubation in COPD
StudyGraphics

#VisualAbstract: High-Intensity Noninvasive Positive Pressure Ventilation Reduces Need for Endotracheal Intubation in COPD

October 2, 2024
#VisualAbstract: Dupilumab Improves Outcomes in COPD with Blood Eosinophil Evidence of Type 2 Inflammation
StudyGraphics

#VisualAbstract: Dupilumab Improves Outcomes in COPD with Blood Eosinophil Evidence of Type 2 Inflammation

June 4, 2024
Next Post
The MR-INFORM trial: fewer patients undergo revascularization when coronary perfusion is assessed with MRI compared to invasive angiography

The MR-INFORM trial: fewer patients undergo revascularization when coronary perfusion is assessed with MRI compared to invasive angiography

Quick Take: Combined Surgery and Extensive Intraoperative Peritoneal Lavage vs Surgery Alone for Treatment of Locally Advanced Gastric Cancer: The SEIPLUS Randomized Clinical Tria

Quick Take: Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Quick Take: Treatment Outcomes of Immune-Related Cutaneous Adverse Events

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large language models show potential to provide feedback on research papers on a large-scale
  • #VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
  • Fecal microbiota transplantation may be more effective than vancomycin in treating primary C. difficile infection
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.